NCT05765890View on ClinicalTrials.gov

Barriers to MASLD Management in Europe: Findings From a Multidisciplinary HCP-survey

CompletedOBSERVATIONAL

Enrollment

675

Participants

Timeline

Start Date

March 24, 2023

Primary Completion Date

September 12, 2023

Study Completion Date

September 12, 2023

Conditions

Non-alcoholic Steatohepatitis (MASH)Non-alcoholic Fatty Liver Disease (MASLD)

Interventions

OTHER

No treatment given

No treatment given

Trial Locations (1)

Unknown

Novo Nordisk Investigational Site, Bangalore

Sponsors

Lead Sponsor

Novo Nordisk A/S

All Listed Sponsors

lead

Novo Nordisk A/S

INDUSTRY